SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-324938
Filing Date
2019-12-27
Accepted
2019-12-27 16:13:12
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d856471ds3.htm S-3 209838
2 EX-5.1 d856471dex51.htm EX-5.1 41080
3 EX-23.1 d856471dex231.htm EX-23.1 4488
4 GRAPHIC g856471g1224053948060.jpg GRAPHIC 3578
5 GRAPHIC g856471g1224054622175.jpg GRAPHIC 1814
6 GRAPHIC g856471stamp_30.jpg GRAPHIC 3172
7 GRAPHIC g856471stamp_35.jpg GRAPHIC 3129
8 GRAPHIC g856471stamp_35b.jpg GRAPHIC 2081
  Complete submission text file 0001193125-19-324938.txt   276490
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235730 | Film No.: 191313852
SIC: 2836 Biological Products, (No Diagnostic Substances)